REFERENCES

1. Pillai AA. Management of de novo malignancies after liver transplantation. Transplant Rev (Orlando) 2015;29:38-41.

2. Piselli P, Busnach G, Fratino L, Citterio F, Ettorre GM, De Paoli P, Serraino D; Immunosuppression and Cancer Study Group. De novo malignancies after organ transplantation: focus on viral infections. Curr Mol Med 2013;13:1217-27.

3. Lykavieris P, Fabre M, Waguet J, Bernard O. Inflammatory pseudotumor after liver transplantation. J Pediatr Gastroenterol Nutr 2000;31:309-12.

4. Bronzino P, Abbo L, Bagnasco F, Barisone P, Dezzani C, Genovese AM, Iannucci P, Ippoliti M, Sacchi M, Aimo I. Intra-abdominal inflammatory myofibroblastic pseudotumor: case report and review of the literature. G Chir 2005;26:362-4.

5. Tufan A, Bahat G. Inflammatory pseudotumors after stem cell transplantation. Hematol Rep 2015;7:5848.

6. Lykavieris P, Fabre M, Waguet J, Bernard O. Inflammatory pseudotumor after liver transplantation. J Pediatr Gastroenterol Nutr 2000;31:309-12.

7. Vroobel K, Judson I, Dainton M, McCormick A, Fisher C, Thway K. ALK-positive inflammatory myofibroblastic tumor harboring ALK gene rearrangement, occurring after allogeneic stem cell transplant in an adult male. Pathol Res Pract 2016;212:743-6.

8. Chaudhary P. Mesenteric inflammatory myofibroblastic tumors. Ann Gastroenterol 2015;28:49-54.